AGN - Allergan gets FDA approval for oral migraine treatment December, 23 2019 03:23 PM Allergan plc Allergan (AGN +0.5%) gets U.S. FDA approval for Ubrelvey (ubrogepant) for the acute treatment of migraine with or without aura in adults.More news on: Allergan plc, Healthcare stocks news, Read more ...